Investigators Dose First Patient in Phase 1 Study of Treos Bio’s PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
14 mai 2018 08h15 HE
|
Treos Bio Corp.
SAN FRANCISCO and LONDON, May 14, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion...
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
09 mai 2018 07h30 HE
|
Adaptimmune Therapeutics plc
- Dosing patients in MAGE-A10 lung cancer study at one billion target cell dose - - Updated MRCLS response data will be presented in an oral presentation at ASCO - - Guidance confirmed, funded...
크라운 바이오사이언스, 2018 미국암학회(aacr) 컨퍼런스에서 혁신적 중개종양학 플랫폼 연구 성과 담긴 포스터 공개
09 mai 2018 05h53 HE
|
Crown Bioscience
샌디에이고, May 09, 2018 (GLOBE NEWSWIRE) -- 크라운 바이오사이언스(Crown Bioscience)가 자사 연구 결과가 담긴 포스터를 오디오 내레이션과 함께 공개했다. 10여건이 넘는 이 포스터들은 최근 있었던 2018 미국 암학회(AACR) 컨퍼런스에서 발표되었으며https://www.crownbio.com/posters/에서...
CrownBio แสดงข้อดีของแพลตฟอร์มมะเร็งวิทยาเพื่อการนำไปใช้ประโยชน์สุดล้ำสมัยในรูปแบบโปสเตอร์วิทยาศาสตร์ในการประชุม AACR 2018
09 mai 2018 05h53 HE
|
Crown Bioscience
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience ซึ่งเป็นบริษัทย่อยที่ถือครองอย่างสมบูรณ์โดย Crown Bioscience International (TWSE:6554)...
CrownBio Menunjukkan Kelebihan Platform Onkologi Translasi Inovatif dalam Poster Saintifik pada Perjumpaan AACR 2018
09 mai 2018 05h53 HE
|
Crown Bioscience
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, syarikat subsidiari yang dimiliki sepenuhnya oleh Crown Bioscience International (TWSE:ticker 6554) dan syarikat perkhidmatan penemuan...
CrownBio Menyajikan Keuntungan dari Platform Onkologi Translasional Inovatif di sesi Poster Ilmiah pada Pertemuan AACR 2018
09 mai 2018 05h53 HE
|
Crown Bioscience
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, anak perusahaan yang dimiliki sepenuhnya oleh Crown Bioscience International (TWSE:ticker 6554) dan merupakan perusahaan jasa penemuan...
クラウンバイオ、aacr 2018総会で科学ポスターに革新的な翻訳/転移腫瘍プラットフォームのメリットを明示
09 mai 2018 05h53 HE
|
Crown Bioscience
サンディエゴ発, May 09, 2018 (GLOBE NEWSWIRE) -- クラウン･バイオサイエンス･インターナショナル (Crown Bioscience International、TWSE:6554)...
CrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 Meeting
08 mai 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services...
CrownBio Launches New Humanized Target Model for Immunotherapy
26 avr. 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company...
Adaptimmune to Report First Quarter 2018 Financial Results and Business Update on Wednesday May 9, 2018
25 avr. 2018 08h00 HE
|
Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORD, U.K., April 25, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the...